Outcome of Inhaler Withdrawal in Patients Receiving Triple Therapy for COPD.
Journal:
Tuberculosis and respiratory diseases
Published Date:
Dec 31, 2015
Abstract
BACKGROUND: The purpose of this study was to document outcomes following withdrawal of a single inhaler (step-down) in chronic obstructive pulmonary disease (COPD) patients on triple therapy (long-acting muscarinic antagonist and a combination of long-acting β2-agonists and inhaled corticosteroid), which a common treatment strategy in clinical practice.
Authors
Keywords
No keywords available for this article.